Abstract
Despite a known optimal treatment protocol for the management of glioblastoma multiforme (GBM), many patients fail to receive complete surgical resection or post-operative radiation therapy (PORT). The underlying reasons behind this disparity are unclear. Our study investigates the influence of regional health system resources on the surgical management and PORT receipt in patients with GBM. Surgical intervention, PORT receipt and patient data for patients diagnosed with GBM were obtained from the years 2004 to 2008 from the NCI Surveillance, Epidemiology, and End Results database and combined with the health system data from the Area Resource File. Four logistic models were constructed to test the effect of health system characteristics on surgical treatment choice and PORT receipt among health service areas (HSAs). We found that younger, married patients in HSAs with higher median incomes were significantly more likely to receive both gross total resection (p < 0.001, p < 0.001, p = 0.002) and PORT (p < 0.001, p < 0.001, p = 0.008). The density of radiation oncology equipped hospitals was also a significant predictor of PORT receipt (p = 0.002). Our findings suggest regional variations in of neuro-oncology services and income may have impact on GBM management. Policies aimed at narrowing disparities in treatment may need to focus on addressing regional variations in oncology resources.
Similar content being viewed by others
References
Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99(3):467–473. doi:10.3171/jns.2003.99.3.0467
Becker KP, Yu J (2012) Status quo–standard-of-care medical and radiation therapy for glioblastoma. Cancer J 18(1):12–19. doi:10.1097/PPO.0b013e318244d7eb
Gorey KM (2009) Breast cancer survival in Canada and the USA: meta-analytic evidence of a Canadian advantage in low-income areas. Int J Epidemiol 38(6):1543–1551. doi:10.1093/ije/dyp193
Ricketts TCHG (2007) Mortality and physician supply: does region hold the key to the paradox? Health Serv Res 42(6):2233–2251
Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K (2011) Physician density and hospitalization for inflammatory bowel disease. Inflamm Bowel Dis 17(2):633–638. doi:10.1002/ibd.21357
Kociol RD, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, Peterson ED, Curtis LH, Hernandez AF (2011) Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failure. Am J Cardiol 108(7):985–991. doi:10.1016/j.amjcard.2011.05.032
Starfield B, Shi L, Grover A, Macinko J (2005) The effects of specialist supply on populations’ health: assessing the evidence. Health Aff (Millwood) Suppl Web Exclusives:W5-97–W5-107. doi:10.1377/hlthaff.w5.97
Iglehart JK (2010) Health reform, primary care, and graduate medical education. N Engl J Med 363(6):584–590. doi:10.1056/NEJMhpr1006115
Aneja S, Smith BD, Gross CP, Wilson LD, Haffty BG, Roberts K, Yu JB (2011) Geographic analysis of the radiation oncology workforce. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2011.01.070
Aneja S, Aneja S, Bordeaux JS (2012) Association of increased dermatologist density with lower melanoma mortality. Arch Dermatol 148(2):174–178. doi:10.1001/archdermatol.2011.345
Odisho AY, Cooperberg MR, Fradet V, Ahmad AE, Carroll PR (2010) Urologist density and county-level urologic cancer mortality. J Clin Oncol 28(15):2499–2504. doi:10.1200/JCO.2009.26.9597
US Department of Health and Human Services HRaSA Area Resource File (ARF): National county-level health resource information database. http://www.arfsys.com. Accessed 18 March 2012
Park HS, Gross CP, Makarov DV, Yu JB (2012) Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2011.10.025
Koshy MVJ, Dolecek TA, Howard A, Mahmood U, Chmura SJ, Weichselbaum RR, McCarthy BJ (2012) Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol 107(1):207–212
Kramm CM, Wagner S, Van Gool S, Schmid H, Strater R, Gnekow A, Rutkowski S, Wolff JE (2006) Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies. Anticancer Res 26(5B):3773–3779
Aghi M BF, Curry WT, Carter BS (2004) Survival after biopsy or resection of supratentorial lobar glioblastoma multiforme: a population-based study, In: Invited talk, congress of neurological surgeons annual meeting
Shinoda J, Sakai N, Murase S, Yano H, Matsuhisa T, Funakoshi T (2001) Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol 52(2):161–171
Chang SM, Barker FG 2nd (2005) Marital status, treatment, and survival in patients with glioblastoma multiforme: a population based study. Cancer 104(9):1975–1984. doi:10.1002/cncr.21399
Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE (2008) Patterns of care in elderly glioblastoma patients. Ann Neurol 64(6):628–634. doi:10.1002/ana.21521
Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, Guillamo JS, Jadaud E, Colin P, Bondiau PY, Menei P, Loiseau H, Bernier V, Honnorat J, Barrie M, Mokhtari K, Mazeron JJ, Bissery A, Delattre JY (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356(15):1527–1535. doi:10.1056/NEJMoa065901
Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R, Hatlevoll R, Lindgren M, Brun A, Lindgren S, Notter G, Andersen AP, Elgen K (1981) Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47(4):649–652
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. doi:10.1056/NEJMoa043330
Sherwood PR, Dahman BA, Donovan HS, Mintz A, Given CW, Bradley CJ (2010) Treatment disparities following the diagnosis of an astrocytoma. J Neurooncol 101(1):67–74. doi:10.1007/s11060-010-0223-8
Lawrence YR, Mishra MV, Werner-Wasik M, Andrews DW, Showalter TN, Glass J, Shen X, Symon Z, Dicker AP (2011) Improving prognosis of glioblastoma in the 21st century: who has benefited most? Cancer 118(17):4228–4234
Sun M, Abdollah F, Liberman D, Abdo A, Thuret R, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI (2011) Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis. Cancer 117(18):4277–4285. doi:10.1002/cncr.25969
Reyes-Ortiz CAGJ, Zhang DD, Freeman JL (2011) Socioeconomic status and chemotherapy use for melanoma in older people. Can J Aging 1:1–11
McBride RB, Lebwohl B, Hershman DL, Neugut AI (2010) Impact of socioeconomic status on extent of lymph node dissection for colon cancer. Cancer Epidemiol Biomarkers Prev 19(3):738–745. doi:10.1158/1055-9965.EPI-09-1086
Shishehbor MH, Litaker D, Pothier CE, Lauer MS (2006) Association of socioeconomic status with functional capacity, heart rate recovery, and all-cause mortality. JAMA 295(7):784–792. doi:10.1001/jama.295.7.784
Stringhini S, Sabia S, Shipley M, Brunner E, Nabi H, Kivimaki M, Singh-Manoux A (2010) Association of socioeconomic position with health behaviors and mortality. JAMA 303(12):1159–1166. doi:10.1001/jama.2010.297
Singal V, Singal AK, Kuo YF (2012) Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis. J Cancer Res Clin Oncol 138(4):715–722. doi:10.1007/s00432-012-1156-8
Evens AM, Antillon M, Aschebrook-Kilfoy B, Chiu BC (2012) Racial disparities in Hodgkin’s lymphoma: a comprehensive population-based analysis. Ann Oncol. doi:10.1093/annonc/mdr578
Robbins AS, Siegel RL, Jemal A (2012) Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol 30(4):401–405. doi:10.1200/JCO.2011.37.5527
Terplan MSN, McNamara EJ, Tracy JK, Temkin SM (2012) Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol 125(1):19–24
Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, Mayer-Steinacker R, Reifenberger G, Weller M (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13(7):707–715. doi:10.1016/S1470-2045(12)70164-X
Jagsi R, Abrahamse P, Hawley ST, Graff JJ, Hamilton AS, Katz SJ (2012) Underascertainment of radiotherapy receipt in surveillance, Epidemiology, and End Results registry data. Cancer 118(2):333–341. doi:10.1002/cncr.26295
Conflict of interest
The authors have no conflicts of interest, financial or otherwise, to report.
Author information
Authors and Affiliations
Corresponding author
Additional information
Sanjay Aneja and Dhruv Khullar contributed equally to this work.
Rights and permissions
About this article
Cite this article
Aneja, S., Khullar, D. & Yu, J.B. The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme. J Neurooncol 112, 393–401 (2013). https://doi.org/10.1007/s11060-013-1068-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-013-1068-8